Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 73.17
-1.28 (-1.72%)
Apr 29, 2026, 3:00 PM CST
SHA:688336 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 46,017 | 36,742 | 13,212 | 13,884 | 7,833 | 11,431 | Upgrade
|
| Market Cap Growth | 166.93% | 178.10% | -4.84% | 77.24% | -31.47% | -24.75% | Upgrade
|
| Enterprise Value | 44,502 | 34,978 | 11,916 | 12,009 | 5,381 | 8,997 | Upgrade
|
| Last Close Price | 74.45 | 59.57 | 21.38 | 22.37 | 12.62 | 18.43 | Upgrade
|
| PE Ratio | 15.56 | 12.67 | 18.75 | 47.13 | 158.90 | 632.98 | Upgrade
|
| Forward PE | 71.59 | 110.99 | 36.46 | 104.70 | 145.14 | 85.29 | Upgrade
|
| PS Ratio | 10.65 | 8.75 | 11.07 | 13.69 | 9.49 | 12.31 | Upgrade
|
| PB Ratio | 5.36 | 4.37 | 2.39 | 2.85 | 1.70 | 2.52 | Upgrade
|
| P/TBV Ratio | 5.54 | 4.46 | 2.47 | 2.98 | 1.78 | 2.63 | Upgrade
|
| P/FCF Ratio | 18.21 | 13.17 | 37289.17 | 76.87 | 640.46 | - | Upgrade
|
| P/OCF Ratio | 16.49 | 12.07 | 46.99 | 33.35 | 33.55 | - | Upgrade
|
| EV/Sales Ratio | 10.30 | 8.33 | 9.98 | 11.84 | 6.52 | 9.69 | Upgrade
|
| EV/EBITDA Ratio | 12.99 | 10.78 | 35.62 | 41.80 | 63.38 | 337.42 | Upgrade
|
| EV/EBIT Ratio | 13.48 | 11.21 | 57.68 | 62.80 | - | - | Upgrade
|
| EV/FCF Ratio | 17.61 | 12.54 | 33631.43 | 66.49 | 439.99 | - | Upgrade
|
| Debt / Equity Ratio | - | - | 0.01 | 0.01 | 0.03 | - | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.15 | 0.17 | 1.77 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 141.19 | 0.28 | 12.27 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.68 | -0.39 | -0.37 | -0.53 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.44 | -1.77 | -6.53 | -6.37 | -28.58 | -88.73 | Upgrade
|
| Net Debt / FCF Ratio | -0.58 | -2.06 | -6163.12 | -10.14 | -198.44 | 4.66 | Upgrade
|
| Asset Turnover | 0.58 | 0.56 | 0.21 | 0.20 | 0.17 | 0.19 | Upgrade
|
| Inventory Turnover | 1.31 | 1.36 | 1.44 | 1.06 | 0.94 | 0.97 | Upgrade
|
| Quick Ratio | 6.44 | 13.22 | 7.51 | 6.54 | 7.27 | 12.18 | Upgrade
|
| Current Ratio | 21.99 | 13.94 | 8.39 | 7.30 | 7.96 | 13.33 | Upgrade
|
| Return on Equity (ROE) | 41.75% | 41.45% | 13.28% | 5.98% | 0.99% | -0.04% | Upgrade
|
| Return on Assets (ROA) | 26.82% | 26.14% | 2.29% | 2.30% | -0.47% | -1.38% | Upgrade
|
| Return on Invested Capital (ROIC) | 57.46% | 90.44% | 6.31% | 6.68% | -1.67% | -5.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 37.10% | 36.70% | 3.70% | 3.80% | -0.80% | -2.30% | Upgrade
|
| Earnings Yield | 6.46% | 7.89% | 5.33% | 2.12% | 0.63% | 0.16% | Upgrade
|
| FCF Yield | 5.49% | 7.60% | 0.00% | 1.30% | 0.16% | -4.44% | Upgrade
|
| Dividend Yield | 0.63% | 0.81% | 0.57% | 0.22% | - | - | Upgrade
|
| Payout Ratio | 2.56% | 2.64% | 7.43% | 0.50% | 2.48% | - | Upgrade
|
| Buyback Yield / Dilution | -0.66% | -0.24% | -0.70% | 0.40% | -2.37% | -2.42% | Upgrade
|
| Total Shareholder Return | -0.02% | 0.57% | -0.12% | 0.62% | -2.37% | -2.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.